Advertisement
Home »

Combination regimen of nirmatrelvir/ritonavir and molnupiravir for the treatment of persistent SARS-CoV-2 infection: a case report and a scoping review of the literature.

May 08, 2023

REFERENCES & ADDITIONAL READING

PubMed

ABOUT THE EXPERTS

  • Davide Marangoni

    Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

    Roberta Maria Antonello

    Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

    Marco Coppi

    Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; Microbiology and Virology Unit, Careggi University Hospital, Florence, Italy.

    Marianna Palazzo

    Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

    Luca Nassi

    Department of Hematology, Careggi University Hospital, Florence, Italy.

    Noemi Streva

    Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

    Laura Povolo

    Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

    Francesca Malentacchi

    Microbiology and Virology Unit, Careggi University Hospital, Florence, Italy.

    Lorenzo Zammarchi

    Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; Infectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy.

    Gian Maria Rossolini

    Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; Microbiology and Virology Unit, Careggi University Hospital, Florence, Italy.

    Alessandro Maria Vannucchi

    Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; Department of Hematology, Careggi University Hospital, Florence, Italy.

    Alessandro Bartoloni

    Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; Infectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy.

    Michele Spinicci

    Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; Infectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy. Electronic address: michele.spinicci@unifi.it.

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


EXPLORE MORE

Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

RELEVANT ARTICLES FOR YOU

Advertisement